Literature DB >> 14551491

Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.

Anna Fernández Lopez1, C Luaces Cubells, J J García García, J Fernández Pou.   

Abstract

BACKGROUND: Procalcitonin (PCT) is a potentially useful marker in pediatric Emergency Departments (ED). The basic objectives of this study were to assess the diagnostic performance of PCT for distinguishing between viral and bacterial infections and for the early detection of invasive bacterial infections in febrile children between 1 and 36 months old comparing it with C-reactive protein (CRP) and to evaluate the utility of a qualitative rapid test for PCT in ED.
METHODS: Prospective, observational and multicenter study that included 445 children who were treated for fever in pediatric ED. Quantitative and qualitative plasma values of PCT and CRP were correlated with the final diagnosis. To obtain the qualitative level of PCT the BRAHMS PCT-Q rapid test was used.
RESULTS: Mean PCT and CRP values in viral infections were 0.26 ng/ml and 15.5 mg/l, respectively. The area under the curve obtained for PCT in distinguishing between viral and bacterial infections was 0.82 (sensitivity, 65.5%; specificity, 94.3%; optimum cutoff, 0.53 ng/ml), whereas for CRP it was 0.78 (sensitivity, 63.5%; specificity, 84.2%; optimum cutoff, 27.5 mg/l). PCT and CRP values in invasive infections (PCT, 24.3 ng/ml; CRP 96.5 mg/l) were significantly higher than those for noninvasive infections (PCT, 0.32 ng/ml; CRP, 23.4 mg/l). The area under the curve for PCT was 0.95 (sensitivity, 91.3%; specificity, 93.5%; optimum cutoff, 0.59 ng/ml), significantly higher (P < 0.001) than that obtained for CRP (0.81). The optimum cutoff value for CRP was >27.5 mg/l with sensitivity and specificity of 78 and 75%, respectively. In infants in whom the evolution of fever was <12 h (n = 104), the diagnostic performance of PCT was also greater than that of CRP (area under the curve, 0.93 for PCT and 0.69 for CRP; P < 0.001). A good correlation between the quantitative values for PCT and the PCT-Q test was obtained in 87% of cases (kappa index, 0.8). The sensitivity of the PCT-Q test (cutoff >0.5 ng/ml) for detecting invasive infections and differentiating them from noninvasive infections was 90.6%, with a specificity of 83.6%.
CONCLUSIONS: PCT offers better specificity than CRP for differentiating between the viral and bacterial etiology of the fever with similar sensitivity. PCT offers better sensibility and specificity than CRP to differentiate between invasive and noninvasive infection. PCT is confirmed as an excellent marker in detecting invasive infections in ED and can even make early detection possible of invasive infections if the evolution of the fever is <12 h. The PCT-Q test has a good correlation with the quantitative values of the marker.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551491     DOI: 10.1097/01.inf.0000091360.11784.21

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  32 in total

Review 1.  In children under age three does procalcitonin help exclude serious bacterial infection in fever without focus?

Authors:  David Herd
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

2.  Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.

Authors:  R Arkader; E J Troster; M R Lopes; R R Júnior; J A Carcillo; C Leone; T S Okay
Journal:  Arch Dis Child       Date:  2005-12-02       Impact factor: 3.791

Review 3.  Management of the non-toxic-appearing acutely febrile child: a 21st century approach.

Authors:  Ravi Jhaveri; Carrie L Byington; Jerome O Klein; Eugene D Shapiro
Journal:  J Pediatr       Date:  2011-05-17       Impact factor: 4.406

4.  Elevated procalcitonin as a diagnostic marker in meningococcal disease.

Authors:  G D Mills; H M Lala; M R Oehley; A B Craig; K Barratt; D Hood; C N Thornley; A Nesdale; N E Manikkam; P Reeve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

5.  Value of Procalcitonin Measurement for Early Evidence of Severe Bacterial Infections in the Pediatric Intensive Care Unit.

Authors:  Andrew J Lautz; Adam C Dziorny; Adam R Denson; Kathleen A O'Connor; Marianne R Chilutti; Rachael K Ross; Jeffrey S Gerber; Scott L Weiss
Journal:  J Pediatr       Date:  2016-08-29       Impact factor: 4.406

6.  Lack of value of midregional pro-adrenomedullin and C-terminal pro-endothelin-1 for prediction of severe bacterial infections in infants with fever without a source.

Authors:  Javier Benito; Carlos Luaces-Cubells; Santiago Mintegi; Eider Astobiza; Lorea Martinez-Indart; Ana Valls-Lafont; Juan-José García-García
Journal:  Eur J Pediatr       Date:  2013-06-22       Impact factor: 3.183

7.  Procalcitonin as the biomarker of inflammation in diagnosis of appendicitis in pediatric patients and prevention of unnecessary appendectomies.

Authors:  Vishal Chandel; Sajjid Hussain Batt; Mohammad Younis Bhat; Nadeem Ulnazeer Kawoosa; Adfar Yousuf; Babar Rashid Zargar
Journal:  Indian J Surg       Date:  2010-12-01       Impact factor: 0.656

8.  Secretory phospholipase A2: a marker of infection in febrile children presenting to a pediatric ED.

Authors:  Karim M Mansour; Frans A Kuypers; Tammy N Wang; Annabeth M Miller; Sandra K Larkin; Claudia R Morris
Journal:  Am J Emerg Med       Date:  2010-08-13       Impact factor: 2.469

9.  Inflammatory molecules expression pattern for identifying pathogen species in febrile patient serum.

Authors:  Kuan-Ting Liu; Yao-Hua Liu; Chun-Yu Lin; Po-Lin Kuo; Meng-Chi Yen
Journal:  Exp Ther Med       Date:  2016-05-10       Impact factor: 2.447

10.  Use of procalcitonin and C-reactive protein in the diagnosis of bacterial infection in infants with severe bronchiolitis.

Authors:  Carme Alejandre; Carmina Guitart; Mònica Balaguer; Isabel Torrús; Sara Bobillo-Perez; Francisco José Cambra; Iolanda Jordan
Journal:  Eur J Pediatr       Date:  2020-09-14       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.